← Leaderboards
Christoph Bausch
Sab Biotherapeutics, Inc.
$335,238
Attributed
$670,476
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$670,476 · 1
By mechanism
R44$670,476 · 1
Top collaborators
- Victor Chester Huber1 shared
Most similar at Sab Biotherapeutics, Inc.
Same institution · by research overlap
- Hua Wu$1,559,434
- Jinan Jiao$378,040
Others in their field
Other Emerging Leaders on “Antibodies”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$169,304,044
- Yunda Huang · Fred Hutchinson Cancer Center$73,421,550
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Hanjoon Ryu$28,519,898
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420
Research focus
AntibodiesAntibody FormationAntibody ResponseAntibody Titer MeasurementAntigensAnti-InfluenzaBiological Response Modifier TherapyCattleClinical ResearchCollectionCommunicable DiseasesCross ReactivityDrug KineticsEfficacy StudyEnsureEvaluationFerretsFutureGenetic EngineeringGrantHemagglutinationHemagglutination Inhibition TestsHigh RiskAdjuvant